YOU MIGHT BE INTERESTED IN
Global Clinical Trial Business Report & Analysis 2008-2018
The global clinical trials business is worth an estimated $50bn in 2008, with a growth of rate of 10%. The market will show considerable growth in the future, as this visiongain report, Global Clinical Trial Business 2008-2018, explains in detail. In recent years, the nature of clinical trials has changed considerably.
...more details
The Indian Pharmaceutical Market
The pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023. The industry's leading Indian Pharma report contains unique market-based research, including detailed interviews with key opinion leaders based in India and abroad.
...more details
Chinese Pharmaceutical Outlook 2008-2023
This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Visiongain predicts that total pharmaceutical revenues in China will increase from approximately $12bn in 2007 to over $30bn in 2013. This is a considerable increase, one that will represent a near tripling of total sales over six years. Strong growth will continue well beyond that period, as this report shows and explains.
...more details
Developing Markets for Pharmaceuticals, 2006-2011
The purpose of this visiongain report is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe at both regional and national level...
...more details
Asian Developing Markets for Pharmaceuticals, 2006-2011
Will the economic growth in new Asian markets allow you to offset global problems? With the Japan market slow and stagnant what other countries in the region offer you the greatest opportunities and how can you succeed in them?
...more details
Latin American Developing Markets for Pharmaceuticals, 2006-2011
The purpose of visiongain's Developing Markets Series is to examine the prospects for the growth of pharmaceutical revenues in the developing economies of Asia, Latin America and Eastern/Central Europe...
...more details